Venture funding worldwide rose sharply in 2021, with investment dollars climbing to nearly $621 billion, more than twice the total invested in 2020. . . . → Read More: Infographic – Venture Funds More Than Double in 2021
|
|||||
Venture funding worldwide rose sharply in 2021, with investment dollars climbing to nearly $621 billion, more than twice the total invested in 2020. . . . → Read More: Infographic – Venture Funds More Than Double in 2021 The government of India granted emergency clearance to two vaccines to prevent Covid-19 disease, both designed in U.S. research labs. . . . → Read More: India Authorizes Covid-19 Vaccines Designed in US A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA. . . . → Read More: Samsung, Biotech Partner on mRNA Vaccine Production A biotechnology company developing treatments in the gut for mental health disorders is receiving a $1 million award for research on pain. . . . → Read More: Biotech Gains $1M for Gut-Brain Pain Research Venture investors worldwide continue to look past the pandemic as investments in start-up enterprises rose to new levels in the U.S., Asia, and elsewhere. . . . → Read More: Infographic – Q3 2021 Venture Funds Continue Banner Year A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells. . . . → Read More: Pharma, Biotech Partner on Off-the-Shelf Cell Therapies A company combining computational genetic analysis and precision medicine discovery for cancer therapies is raising $43 million in its first venture round. . . . → Read More: Precision Cancer Meds Company Raises $43M in Early Funds Moderna Inc. and South Korea signed agreements Saturday on joint research and manufacturing opportunities for vaccines against viruses in Korea. . . . → Read More: Moderna Expands Vaccine Research, Mfring in Asia A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million. . . . → Read More: Gene Therapy Company Starts-Up, Gains $200M A provider of drug discovery services based on artificial intelligence says in 18 months it identified and tested in mice a new drug for a chronic lung disease. . . . → Read More: AI Process Discovers, Tests Fibrosis Drug in 18 Months |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |